BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Limosilactobacillus fermentum {L. fermentum} - Ruminococcus |
📓
Protective Potential of Limosilactobacillus fermentum Strains and Their Mixture on Inflammatory Bowel Disease via Regulating Gut Microbiota in Mice. Journal of microbiology and biotechnology (J Microbiol Biotechnol ) Vol: 35 Issue Pages: e2410009 Pub: 2024 Dec 10 Epub: 2024 Dec 10 Authors Joung JY , Choi K , Lee JH , Oh NS , Html Article Publication |
| Limosilactobacillus fermentum {L. fermentum} - Ruminococcus |
👶
Lactobacillus fermentum FTDC 8312 combats hypercholesterolemia via alteration of gut microbiota. Journal of biotechnology (J Biotechnol ) Vol: 262 Issue Pages: 75-83 Pub: 2017 Nov 20 Epub: 2017 Sep 19 Authors Lye HS , Kato T , Low WY , Taylor TD , Prakash T , Lew LC , Ohno H , Liong MT , Publication Publication |
| Limosilactobacillus fermentum {L. fermentum} - Ruminococcus |
👪
Revealing the Potential Impacts of Nutraceuticals Formulated with Freeze-Dried Jabuticaba Peel and Limosilactobacillus fermentum Strains Candidates for Probiotic Use on Human Intestinal Microbiota. Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: 16 Issue 5 Pages: 1773-1789 Pub: 2024 Oct Epub: 2023 Aug 10 Authors da Silva JYP , do Nascimento HMA , de Albuquerque TMR , Sampaio KB , Dos Santos Lima M , Monteiro M , Leite IB , da Silva EF , do Nascimento YM , da Silva MS , Tavares JF , de Brito Alves JL , de Oliveira MEG , de Souza EL , Publication |
| Limosilactobacillus fermentum {L. fermentum} - Ruminococcus |
👶
Anti-inflammatory probiotics HF05 and HF06 synergistically alleviate ulcerative colitis and secondary liver injury. Food & function (Food Funct ) Vol: 15 Issue 7 Pages: 3765-3777 Pub: 2024 Apr 2 Epub: 2024 Apr 2 Authors Liu C , Qi X , Liu X , Sun Y , Mao K , Shen G , Ma Y , Li Q , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
